To harness the power of Immuno-oncology, a deep understanding of the intricate workings of the anti-tumor immune response is required.
With mechanisms still partially veiled and hypotheses emerging from all angles, one thing is clear - the complexity of Immuno-oncology trials has brought new challenges to all corners of drug development, including clinical biomarker testing.
Download our 2 webinars to learn about the challenges and critical success factors associated with implementing biomarker testing in Immuno-oncology trials
Webinar 1: From eligibility to exploratory: planning and implementing biomarker testing for immuno-oncology trials
Key learning objective:
Webinar 2: Keeping pace with immuno-oncology research breakthroughs and biomarker identification
- Gain knowledge on key considerations for biomarker defined Immuno-oncology clinical trials and the development of companion diagnostics
Key learning objectives:
You can also view our recorded webinar presentations on- demand.
- Learn more about key applications for RNA-Seq in immuno-oncology
- Learn how RNA-Seq provides high-throughput, comprehensive, direct measurement of functionally relevant molecular processes